Pulse Biosciences, Inc. Current Liabilities
Pulse Biosciences, Inc. (PLSE) had Current Liabilities of $10.98 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $10.98M.
- 2026-03-31: Liabilities, Current $9.80M.
- 2025-12-31: Liabilities, Current $7.92M.
- 2025-09-30: Liabilities, Current $9.70M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.98M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.80M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $7.92M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.70M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $8.98M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $7.76M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $10.05M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $6.74M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $5.96M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $5.08M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $6.71M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.61M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $6.99M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.98M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $7.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $7.56M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $8.90M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $6.71M 10-Q · filed 2024-10-30 | $8.52M 10-K · filed 2022-03-31 |
| 2021-09-30 | $9.52M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $9.84M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $8.53M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $7.58M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $6.00M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.89M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.38M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.46M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $4.05M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.45M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.12M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $3.11M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.35M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $3.07M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $2.19M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.21M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $2.47M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.97M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.24M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.02M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $967.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $590.00K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $650.00K 10-Q · filed 2016-06-27 | |
| 2015-12-31 | $660.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |